Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Målrettet terapi rettet av genetisk testing for behandling av pasienter med lokalt avanserte eller avanserte solide svulster, ComboMATCH Registration Trial

11. november 2026 oppdatert av: National Cancer Institute (NCI)

Molekylær analyse for valg av kombinasjonsterapi (ComboMATCH)

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Studieoversikt

Detaljert beskrivelse

PRIMARY OBJECTIVE:

I. To register, allocate, and assign patients to ComboMATCH treatment trials.

SECONDARY OBJECTIVES:

I. To evaluate the rate of positive outcomes in defined cohorts within treatment trials of treatment combinations including targeted therapies for molecularly defined populations, and also in the subset of treatment trials where the treatments are supported by in vivo models.

II. To perform quality control of the patients registered in the form of pathological confirmation of disease and sub-type to confirm diagnosis and treatment arm allocation.

SECONDARY CORRELATIVE OBJECTIVES:

I. Assess the concordance of the central molecular characterization of the pre-treatment biopsy samples with the genetic readouts from the Designated Laboratories (DLs) for patients enrolled on the ComboMATCH treatment trials.

II. To assess how the registration diagnostic tumor mutation profile and pre-treatment biopsy profile compare to the circulating tumor-derived deoxyribonucleic acid (ctDNA) mutation profile from plasma.

EXPLORATORY OBJECTIVE:

I. Assess association between ComboMATCH treatment trials outcomes (positive or negative) with the type of rationale for the selected drug combinations and the type of rationale for the gene variant/combination for selection (e.g., whether the trial was based on targeted therapies for molecularly defined populations, those that were supported by in vivo models, and those that were supported by empiric clinical data).

OUTLINE:

REGISTRATION: Patients undergo tumor mutational screening of previously-collected tumor samples for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing. Patients who are 18 years or older and have biopsiable disease undergo a new biopsy for research purposes prior to initiating treatment on the ComboMATCH treatment trial.

TREATMENT: Patients with mutations targeted to investigational combination therapies are assigned to 1 of 20 treatment subprotocols.

EAY191-N4: Patients with RAS pathway mutant ovarian or endometrial cancer are randomized to 1 of 2 arms.

ARM I: Patients receive selumetinib orally (PO) twice daily (BID) and olaparib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as echocardiogram (ECHO) or multigated acquisition (MUGA), and computed tomography (CT) scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

ARM II: Patients receive selumetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

EAY191-N2: Patients with inactivating or inferred inactivating NF1 alterations, and hormone receptor positive, HER2-negative metastatic breast cancer. Patients who are fulvestrant naive are assigned to Cohort I, while patients who are fulvestrant resistant are assigned to Cohort II.

COHORT I: Patients are randomized to 1 of 2 arms.

ARM I:Patients receive fulvestrant intramuscularly (IM) on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles and binimetinib PO BID on days 15 to 28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a CT, magnetic resonance imaging (MRI), or bone scan, ECHO or MUGA, and tumor biopsy, as well as possible blood sample collection during screening and on study.

ARM II: Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who progress on fulvestrant alone may migrate to cohort II if they meet the migration eligibility criteria. Patients not willing to migrate to cohort II will have further therapy at the investigator's discretion. Patients undergo a CT, MRI, or bone scan and tumor biopsy, as well as ECHO or MUGA and possible blood sample collection during screening and on study.

COHORT II: Patients receive fulvestrant IM on day 1 of each cycle and binimetinib PO BID on days 15-28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo a CT, MRI, or bone scan, ECHO or MUGA and tumor biopsy, as well as possible blood sample collection during screening and on study.

EAY191-E4: Patients with solid tumors who previously underwent taxane therapy.

Patients receive nilotinib hydrochloride monohydrate PO BID on days 1-28 and paclitaxel intravenously (IV) over 1 hour on days 1, 8, and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT or MRI during screening or cycle 1 day 1, every 2 cycles for 1 year, every 3 cycles for patients on study for more than 1 year, and every 4 cycles for patients on study for more than 3 years and may also undergo CT or MRI during follow-up every 3 months for 2 years and then every 6 months for 1 year if clinically indicated. Patients also undergo collection of blood samples at baseline, cycle 2 day 1, and optionally at progression as well as tumor biopsy at baseline and optionally at progression.

EAY191-A3: Patients with KRAS/NRAS/BRAF mutated low-grade serous ovarian cancer (LGSOC) naive to MEK or CDK4/6 inhibitor therapy are randomized to either combination cohort 1 or monotherapy cohort 1. Patients with LGSOC who have received prior MEK inhibitor therapy are assigned to combination cohort 2. Patients with KRAS/NRAS/HRAS/non-V600E BRAF mutated pancreatic cancer are assigned to combination cohort 3. Patients with all other KRAS/NRAS/HRAS mutated tumor types (excluding LGSOC, non-small cell lung cancer, colorectal cancer, pancreatic, and melanoma) are assigned to combination cohort 4.

COMBINATION COHORTS 1, 2, 3, 4: Patients receive palbociclib PO and binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

MONOTHERAPY COHORT 1: Patients receive binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

EAY191-S3: Patients with an activating AKT mutation solid tumor.

Patients receive paclitaxel IV on days 1, 8, and 15 and ipatasertib PO on days 1-21 of each cycle. Treatment repeats every 28 days for up to 35 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo a CT or MRI and blood collection throughout the trial. Patients also undergo a tumor biopsy during screening and optionally during follow-up.

EAY191-A6: Patients with RAS/RAF/MEK/ERK mutant biliary tract cancers are randomized to 1 of 2 arms.

ARM 1: Patients receive leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo echocardiogram (ECHO) and multigated acquisition scan (MUGA) during screening and on study, a CT with contrast, MRI, or a fludeoxyglucose F-18 positron emission tomography (FDG-PET) during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

ARM 2: Patients receive binimetinib PO, leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or an FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

EAY191-E5: Patients are assigned to 1 of 2 cohorts.

COHORT I: Patients who have never received a KRAS G12C inhibitor are randomized to arms A or B.

ARM A: Patients receive sotorasib PO once daily (QD) on days 1-28 and panitumumab intravenously IV on days 1 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

ARM B: Patients receive sotorasib PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients with disease progression may cross-over to cohort II. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

COHORT II: Patients who have received a KRAS G12C inhibitor are assigned to arm C.

ARM C: Patients receive combination therapy as in Arm A.

EAY191-A2: Patients are assigned to 1 of 3 cohorts.

COHORT 1: PARP-inhibitor naive patients are assigned to Arm A.

ARM A: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

COHORT 2: PARP-inhibitor naive patients are randomized to 1 of 2 arms.

ARM B: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

ARM C: Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients experiencing disease progression have the option to migrate to Cohort 3, Arm D. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

COHORT 3: PARP-inhibitor resistant patients are assigned to Arm D.

ARM D: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

EAY191-N5: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

ARM II: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Studietype

Intervensjonell

Registrering (Antatt)

2900

Fase

  • Fase 2

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35233
        • Rekruttering
        • University of Alabama at Birmingham Cancer Center
        • Hovedetterforsker:
          • Rebecca C. Arend
        • Ta kontakt med:
      • Mobile, Alabama, Forente stater, 36688
        • Rekruttering
        • University of South Alabama Mitchell Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ahmed Abdalla
    • Alaska
      • Anchorage, Alaska, Forente stater, 99508
    • Arizona
      • Goodyear, Arizona, Forente stater, 85338
        • Rekruttering
        • CTCA at Western Regional Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 623-207-3000
        • Hovedetterforsker:
          • Sagun Shrestha
      • Kingman, Arizona, Forente stater, 86401
        • Rekruttering
        • Kingman Regional Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Phoenix, Arizona, Forente stater, 85054
        • Suspendert
        • Mayo Clinic Hospital in Arizona
    • Arkansas
      • Jonesboro, Arkansas, Forente stater, 72401
        • Rekruttering
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
    • California
      • Arroyo Grande, California, Forente stater, 93420
        • Rekruttering
        • PCR Oncology
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Carmichael, California, Forente stater, 95608
      • Carmichael, California, Forente stater, 95608
      • Dublin, California, Forente stater, 94568
        • Aktiv, ikke rekrutterende
        • Epic Care-Dublin
      • Elk Grove, California, Forente stater, 95758
      • Encinitas, California, Forente stater, 92024
        • Rekruttering
        • UC San Diego Health System - Encinitas
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 760-536-7700
        • Hovedetterforsker:
          • Peter Vu
      • La Jolla, California, Forente stater, 92093
        • Rekruttering
        • UC San Diego Moores Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Vu
      • Los Angeles, California, Forente stater, 90048
        • Rekruttering
        • Cedars-Sinai Medical Center
        • Hovedetterforsker:
          • Omid Hamid
        • Ta kontakt med:
      • Los Angeles, California, Forente stater, 90025
        • Rekruttering
        • The Angeles Clinic and Research Institute - West Los Angeles Office
        • Ta kontakt med:
        • Hovedetterforsker:
          • Omid Hamid
      • Martinez, California, Forente stater, 94553-3156
        • Aktiv, ikke rekrutterende
        • Contra Costa Regional Medical Center
      • Orange, California, Forente stater, 92868
        • Rekruttering
        • Children's Hospital of Orange County
        • Ta kontakt med:
        • Hovedetterforsker:
          • Elyssa M. Rubin
      • Orange, California, Forente stater, 92868
        • Rekruttering
        • Saint Joseph Hospital - Orange
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 714-734-6220
        • Hovedetterforsker:
          • Timothy E. Byun
      • Palo Alto, California, Forente stater, 94304
        • Rekruttering
        • Stanford Cancer Institute Palo Alto
        • Hovedetterforsker:
          • James M. Ford
        • Ta kontakt med:
      • Palo Alto, California, Forente stater, 94304
        • Rekruttering
        • VA Palo Alto Health Care System
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-455-0057
        • Hovedetterforsker:
          • Harlan A. Pinto
      • Rocklin, California, Forente stater, 95765
      • Sacramento, California, Forente stater, 95816
      • San Diego, California, Forente stater, 92103
        • Rekruttering
        • UC San Diego Medical Center - Hillcrest
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peter Vu
      • San Diego, California, Forente stater, 92123
        • Rekruttering
        • Sharp Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Charles H. Redfern
      • San Francisco, California, Forente stater, 94158
        • Suspendert
        • UCSF Medical Center-Mission Bay
      • Santa Monica, California, Forente stater, 90404
        • Rekruttering
        • Saint John's Cancer Institute
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 310-582-7448
        • Hovedetterforsker:
          • Reva K. Basho
      • Walnut Creek, California, Forente stater, 94597
        • Aktiv, ikke rekrutterende
        • Epic Care Cyberknife Center
      • Whittier, California, Forente stater, 90602
        • Suspendert
        • Presbyterian Intercommunity Hospital
      • Woodland, California, Forente stater, 95695
    • Colorado
      • Aurora, Colorado, Forente stater, 80045
        • Rekruttering
        • UCHealth University of Colorado Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Hovedetterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forente stater, 80524
        • Rekruttering
        • Poudre Valley Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 970-297-6150
        • Hovedetterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forente stater, 80528
        • Rekruttering
        • Cancer Care and Hematology-Fort Collins
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bradley R. Corr
      • Greeley, Colorado, Forente stater, 80631
        • Rekruttering
        • UCHealth Greeley Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bradley R. Corr
      • Loveland, Colorado, Forente stater, 80538
        • Rekruttering
        • Medical Center of the Rockies
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 970-203-7083
        • Hovedetterforsker:
          • Bradley R. Corr
    • Delaware
      • Newark, Delaware, Forente stater, 19713
        • Rekruttering
        • Helen F Graham Cancer Center
        • Hovedetterforsker:
          • Gregory A. Masters
        • Ta kontakt med:
      • Newark, Delaware, Forente stater, 19713
        • Rekruttering
        • Medical Oncology Hematology Consultants PA
        • Hovedetterforsker:
          • Gregory A. Masters
        • Ta kontakt med:
    • Florida
      • Aventura, Florida, Forente stater, 33180
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Aventura
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 954-461-2180
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Coral Gables, Florida, Forente stater, 33146
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Coral Gables
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Deerfield Beach, Florida, Forente stater, 33442
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Deerfield Beach
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Fort Lauderdale, Florida, Forente stater, 33316
        • Aktiv, ikke rekrutterende
        • Broward Health Medical Center
      • Gainesville, Florida, Forente stater, 32610
        • Rekruttering
        • UF Health Cancer Institute - Gainesville
        • Ta kontakt med:
        • Hovedetterforsker:
          • Thomas J. George
      • Jacksonville, Florida, Forente stater, 32224-9980
        • Rekruttering
        • Mayo Clinic in Florida
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 855-776-0015
        • Hovedetterforsker:
          • Aaron S. Mansfield
      • Miami, Florida, Forente stater, 33136
        • Rekruttering
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Miami, Florida, Forente stater, 33176
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Kendall
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • North Miami, Florida, Forente stater, 33181
        • Rekruttering
        • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
        • Ta kontakt med:
      • Plantation, Florida, Forente stater, 33324
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Plantation
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Hovedetterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
    • Georgia
      • Newnan, Georgia, Forente stater, 30265
        • Aktiv, ikke rekrutterende
        • CTCA at Southeastern Regional Medical Center
    • Hawaii
      • Honolulu, Hawaii, Forente stater, 96826
        • Rekruttering
        • Kapiolani Medical Center for Women and Children
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-983-6090
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Queen's Cancer Cenrer - POB I
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-532-0315
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Queen's Medical Center
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-545-8548
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Straub Clinic and Hospital
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-522-4333
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • University of Hawaii Cancer Center
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-586-2979
      • Honolulu, Hawaii, Forente stater, 96817
        • Rekruttering
        • Queen's Cancer Center - Kuakini
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-531-8521
      • ‘Aiea, Hawaii, Forente stater, 96701
        • Rekruttering
        • Hawaii Cancer Care - Westridge
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
      • ‘Aiea, Hawaii, Forente stater, 96701
        • Rekruttering
        • Pali Momi Medical Center
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-486-6000
      • ‘Ewa Beach, Hawaii, Forente stater, 96706
        • Rekruttering
        • The Queen's Medical Center - West Oahu
        • Hovedetterforsker:
          • Jeffrey L. Berenberg
        • Ta kontakt med:
    • Idaho
      • Boise, Idaho, Forente stater, 83712
        • Rekruttering
        • Saint Luke's Cancer Institute - Boise
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Boise, Idaho, Forente stater, 83706
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Boise
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Caldwell, Idaho, Forente stater, 83605
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Caldwell
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Coeur d'Alene, Idaho, Forente stater, 83814
        • Rekruttering
        • Kootenai Health - Coeur d'Alene
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Fruitland, Idaho, Forente stater, 83619
        • Rekruttering
        • Saint Luke's Cancer Institute - Fruitland
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Meridian, Idaho, Forente stater, 83642
        • Rekruttering
        • Saint Luke's Cancer Institute - Meridian
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Nampa, Idaho, Forente stater, 83687
        • Rekruttering
        • Saint Luke's Cancer Institute - Nampa
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Nampa, Idaho, Forente stater, 83687
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Nampa
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Post Falls, Idaho, Forente stater, 83854
        • Rekruttering
        • Kootenai Clinic Cancer Services - Post Falls
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Sandpoint, Idaho, Forente stater, 83864
        • Rekruttering
        • Kootenai Clinic Cancer Services - Sandpoint
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Twin Falls, Idaho, Forente stater, 83301
        • Rekruttering
        • Saint Luke's Cancer Institute - Twin Falls
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
    • Illinois
      • Barrington, Illinois, Forente stater, 60010
        • Rekruttering
        • Advocate Good Shepherd Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-842-4847
        • Hovedetterforsker:
          • Antony Ruggeri
      • Bloomington, Illinois, Forente stater, 61704
        • Rekruttering
        • Illinois CancerCare-Bloomington
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Canton, Illinois, Forente stater, 61520
        • Rekruttering
        • Illinois CancerCare-Canton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Carterville, Illinois, Forente stater, 62918
        • Rekruttering
        • SIH Cancer Institute
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Carthage, Illinois, Forente stater, 62321
        • Rekruttering
        • Illinois CancerCare-Carthage
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Centralia, Illinois, Forente stater, 62801
        • Rekruttering
        • Centralia Oncology Clinic
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Chicago, Illinois, Forente stater, 60637
        • Rekruttering
        • University of Chicago Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ardaman Shergill
      • Chicago, Illinois, Forente stater, 60611
        • Rekruttering
        • Northwestern University
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
      • Chicago, Illinois, Forente stater, 60612
        • Rekruttering
        • University of Illinois
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 312-355-3046
        • Hovedetterforsker:
          • Ryan Nguyen
      • Chicago, Illinois, Forente stater, 60612
        • Rekruttering
        • John H Stroger Jr Hospital of Cook County
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 312-864-5204
        • Hovedetterforsker:
          • Deimante M. Tamkus
      • Chicago, Illinois, Forente stater, 60657
        • Rekruttering
        • Advocate Illinois Masonic Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 773-296-5360
        • Hovedetterforsker:
          • Antony Ruggeri
      • Chicago, Illinois, Forente stater, 60608
        • Rekruttering
        • Mount Sinai Hospital Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 773-257-5960
          • E-post: suhi@sinai.org
        • Hovedetterforsker:
          • Pam G. Khosla
      • Crystal Lake, Illinois, Forente stater, 60014
        • Rekruttering
        • AMG Crystal Lake - Oncology
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Danville, Illinois, Forente stater, 61832
        • Rekruttering
        • Carle at The Riverfront
        • Hovedetterforsker:
          • Tanmay Sahai
        • Ta kontakt med:
      • DeKalb, Illinois, Forente stater, 60115
        • Rekruttering
        • Northwestern Medicine Cancer Center Kishwaukee
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
      • Decatur, Illinois, Forente stater, 62526
        • Rekruttering
        • Cancer Care Specialists of Illinois - Decatur
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Decatur, Illinois, Forente stater, 62526
        • Rekruttering
        • Decatur Memorial Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Dixon, Illinois, Forente stater, 61021
        • Rekruttering
        • Illinois CancerCare-Dixon
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 815-285-7800
      • Downers Grove, Illinois, Forente stater, 60515
        • Rekruttering
        • Advocate Good Samaritan Hospital
        • Hovedetterforsker:
          • Antony Ruggeri
        • Ta kontakt med:
      • Effingham, Illinois, Forente stater, 62401
        • Rekruttering
        • Carle Physician Group-Effingham
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tanmay Sahai
      • Effingham, Illinois, Forente stater, 62401
        • Rekruttering
        • Crossroads Cancer Center
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Elgin, Illinois, Forente stater, 60123
        • Rekruttering
        • Advocate Sherman Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-429-2907
        • Hovedetterforsker:
          • Antony Ruggeri
      • Eureka, Illinois, Forente stater, 61530
        • Rekruttering
        • Illinois CancerCare-Eureka
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Evanston, Illinois, Forente stater, 60201
        • Rekruttering
        • NorthShore University HealthSystem-Evanston Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Galesburg, Illinois, Forente stater, 61401
        • Rekruttering
        • Illinois CancerCare-Galesburg
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Geneva, Illinois, Forente stater, 60134
        • Rekruttering
        • Northwestern Medicine Cancer Center Delnor
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
      • Glenview, Illinois, Forente stater, 60026
        • Rekruttering
        • NorthShore University HealthSystem-Glenbrook Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Glenview, Illinois, Forente stater, 60026
        • Rekruttering
        • Northwestern Medicine Glenview Outpatient Center
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 312-695-1102
      • Grayslake, Illinois, Forente stater, 60030
        • Rekruttering
        • Northwestern Medicine Grayslake Outpatient Center
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 312-695-1102
      • Harvey, Illinois, Forente stater, 60426
        • Rekruttering
        • Ingalls Memorial Hospital
        • Hovedetterforsker:
          • James A. Wallace
        • Ta kontakt med:
      • Hazel Crest, Illinois, Forente stater, 60429
        • Rekruttering
        • Advocate South Suburban Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 708-799-9995
        • Hovedetterforsker:
          • Antony Ruggeri
      • Highland Park, Illinois, Forente stater, 60035
        • Rekruttering
        • NorthShore University HealthSystem-Highland Park Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Kewanee, Illinois, Forente stater, 61443
        • Rekruttering
        • Illinois CancerCare-Kewanee Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Lake Forest, Illinois, Forente stater, 60045
        • Rekruttering
        • Northwestern Medicine Lake Forest Hospital
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
      • Libertyville, Illinois, Forente stater, 60048
        • Rekruttering
        • AMG Libertyville - Oncology
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Libertyville, Illinois, Forente stater, 60048
        • Rekruttering
        • Condell Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Macomb, Illinois, Forente stater, 61455
        • Rekruttering
        • Illinois CancerCare-Macomb
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Mattoon, Illinois, Forente stater, 61938
        • Rekruttering
        • Carle Physician Group-Mattoon/Charleston
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tanmay Sahai
      • Maywood, Illinois, Forente stater, 60153
        • Rekruttering
        • Loyola University Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 708-226-4357
        • Hovedetterforsker:
          • Nan Sethakorn
      • Mount Vernon, Illinois, Forente stater, 62864
        • Rekruttering
        • SSM Health Good Samaritan
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
      • New Lenox, Illinois, Forente stater, 60451
        • Rekruttering
        • UC Comprehensive Cancer Center at Silver Cross
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ardaman Shergill
      • Normal, Illinois, Forente stater, 61761
        • Rekruttering
        • Carle BroMenn Medical Center
        • Hovedetterforsker:
          • Tanmay Sahai
        • Ta kontakt med:
      • Normal, Illinois, Forente stater, 61761
        • Rekruttering
        • Carle Cancer Institute Normal
        • Hovedetterforsker:
          • Tanmay Sahai
        • Ta kontakt med:
      • O'Fallon, Illinois, Forente stater, 62269
        • Rekruttering
        • Cancer Care Center of O'Fallon
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Oak Lawn, Illinois, Forente stater, 60453-2699
        • Rekruttering
        • Advocate Christ Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-323-8622
        • Hovedetterforsker:
          • Antony Ruggeri
      • Orland Park, Illinois, Forente stater, 60462
        • Rekruttering
        • University of Chicago Medicine-Orland Park
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ardaman Shergill
      • Orland Park, Illinois, Forente stater, 60462
      • Ottawa, Illinois, Forente stater, 61350
        • Rekruttering
        • Illinois CancerCare-Ottawa Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Park Ridge, Illinois, Forente stater, 60068
        • Rekruttering
        • Advocate Lutheran General Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-384-3621
        • Hovedetterforsker:
          • Antony Ruggeri
      • Pekin, Illinois, Forente stater, 61554
        • Rekruttering
        • Illinois CancerCare-Pekin
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Peoria, Illinois, Forente stater, 61615
        • Rekruttering
        • Illinois CancerCare-Peoria
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Peru, Illinois, Forente stater, 61354
        • Rekruttering
        • Illinois CancerCare-Peru
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Princeton, Illinois, Forente stater, 61356
        • Rekruttering
        • Illinois CancerCare-Princeton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Rockford, Illinois, Forente stater, 61114
        • Rekruttering
        • Mercyhealth Cancer Institute - Rockford
        • Hovedetterforsker:
          • Mayur Narkhede
        • Ta kontakt med:
      • Shiloh, Illinois, Forente stater, 62269
        • Rekruttering
        • Memorial Hospital East
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • Springfield, Illinois, Forente stater, 62702
        • Rekruttering
        • Southern Illinois University School of Medicine
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 217-545-7929
      • Springfield, Illinois, Forente stater, 62702
        • Rekruttering
        • Springfield Clinic
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-444-7541
      • Springfield, Illinois, Forente stater, 62781
        • Rekruttering
        • Springfield Memorial Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Urbana, Illinois, Forente stater, 61801
        • Rekruttering
        • Carle Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tanmay Sahai
      • Warrenville, Illinois, Forente stater, 60555
        • Rekruttering
        • Northwestern Medicine Cancer Center Warrenville
        • Hovedetterforsker:
          • Devalingam Mahalingam
        • Ta kontakt med:
      • Washington, Illinois, Forente stater, 61571
        • Rekruttering
        • Illinois CancerCare - Washington
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Zion, Illinois, Forente stater, 60099
        • Aktiv, ikke rekrutterende
        • Midwestern Regional Medical Center
    • Indiana
      • Crown Point, Indiana, Forente stater, 46307
        • Rekruttering
        • UChicago Medicine Northwest Indiana
        • Hovedetterforsker:
          • Ardaman Shergill
        • Ta kontakt med:
      • Michigan City, Indiana, Forente stater, 46360
        • Rekruttering
        • Woodland Cancer Care Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • William H. Bae
      • Richmond, Indiana, Forente stater, 47374
        • Suspendert
        • Reid Health
      • South Bend, Indiana, Forente stater, 46601
        • Aktiv, ikke rekrutterende
        • Memorial Hospital of South Bend
    • Iowa
      • Ankeny, Iowa, Forente stater, 50023
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Forente stater, 52403
        • Rekruttering
        • Mercy Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 319-365-4673
        • Hovedetterforsker:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Forente stater, 52403
        • Rekruttering
        • Oncology Associates at Mercy Medical Center
        • Hovedetterforsker:
          • Deborah W. Wilbur
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 319-363-2690
      • Des Moines, Iowa, Forente stater, 50314
        • Rekruttering
        • Mercy Medical Center - Des Moines
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Richard L. Deming
      • Des Moines, Iowa, Forente stater, 50309
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forente stater, 50314
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Waukee, Iowa, Forente stater, 50263
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
    • Kentucky
      • Lexington, Kentucky, Forente stater, 40536
        • Rekruttering
        • University of Kentucky/Markey Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 859-257-3379
        • Hovedetterforsker:
          • Susanne M. Arnold
      • Lexington, Kentucky, Forente stater, 40509
        • Rekruttering
        • CommonSpirit Saint Joseph Medical Center - East Lexington
        • Hovedetterforsker:
          • Loretta J. Nastoupil
        • Ta kontakt med:
      • Paducah, Kentucky, Forente stater, 42003
        • Aktiv, ikke rekrutterende
        • Mercy Health - Paducah Cancer Center
    • Louisiana
      • Metairie, Louisiana, Forente stater, 70006
        • Aktiv, ikke rekrutterende
        • East Jefferson General Hospital
      • New Orleans, Louisiana, Forente stater, 70121
        • Rekruttering
        • Ochsner Medical Center Jefferson
        • Hovedetterforsker:
          • John T. Cole
        • Ta kontakt med:
      • New Orleans, Louisiana, Forente stater, 70112
        • Aktiv, ikke rekrutterende
        • University Medical Center New Orleans
    • Maine
      • Augusta, Maine, Forente stater, 04330
        • Rekruttering
        • Harold Alfond Center for Cancer Care
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 207-626-4855
        • Hovedetterforsker:
          • Leslie S. Bradford
      • Brewer, Maine, Forente stater, 04412
        • Rekruttering
        • Lafayette Family Cancer Center-EMMC
        • Hovedetterforsker:
          • Sarah J. Sinclair
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-987-3005
      • Scarborough, Maine, Forente stater, 04074
        • Rekruttering
        • MaineHealth Maine Medical Center- Scarborough
        • Hovedetterforsker:
          • Leslie S. Bradford
        • Ta kontakt med:
      • South Portland, Maine, Forente stater, 04106
        • Rekruttering
        • MaineHealth Cancer Care and IV Therapy - South Portland
        • Hovedetterforsker:
          • Leslie S. Bradford
        • Ta kontakt med:
    • Maryland
      • Baltimore, Maryland, Forente stater, 21201
        • Rekruttering
        • University of Maryland/Greenebaum Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-888-8823
        • Hovedetterforsker:
          • Ranee Mehra
      • Bethesda, Maryland, Forente stater, 20892
        • Rekruttering
        • National Institutes of Health Clinical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-411-1222
        • Hovedetterforsker:
          • A P. Chen
      • Bethesda, Maryland, Forente stater, 20889-5600
        • Rekruttering
        • Walter Reed National Military Medical Center
        • Hovedetterforsker:
          • Jeremy G. Perkins
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 301-319-2100
      • Cumberland, Maryland, Forente stater, 21502
        • Rekruttering
        • UPMC Western Maryland
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 240-964-1400
        • Hovedetterforsker:
          • Adam M. Brufsky
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02215
        • Rekruttering
        • Dana-Farber Cancer Institute
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-442-3324
        • Hovedetterforsker:
          • Geoffrey I. Shapiro
      • Boston, Massachusetts, Forente stater, 02111
      • Boston, Massachusetts, Forente stater, 02215
        • Aktiv, ikke rekrutterende
        • Beth Israel Deaconess Medical Center
      • Springfield, Massachusetts, Forente stater, 01199
        • Rekruttering
        • Baystate Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tashanna K. Myers
      • Stoneham, Massachusetts, Forente stater, 02180
        • Rekruttering
        • Tufts Medical Center Cancer Center Stoneham
        • Hovedetterforsker:
          • Francis W. Nugent
        • Ta kontakt med:
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • Rekruttering
        • University of Michigan Rogel Cancer Center
        • Hovedetterforsker:
          • Anne F. Schott
        • Ta kontakt med:
      • Ann Arbor, Michigan, Forente stater, 48106
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Battle Creek, Michigan, Forente stater, 49017
        • Rekruttering
        • Bronson Battle Creek
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Brighton, Michigan, Forente stater, 48114
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Brighton, Michigan, Forente stater, 48116
        • Rekruttering
        • University of Michigan - Brighton Center for Specialty Care
        • Hovedetterforsker:
          • Anne F. Schott
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-865-1125
      • Brighton, Michigan, Forente stater, 48114
        • Rekruttering
        • Trinity Health Medical Center - Brighton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Canton, Michigan, Forente stater, 48188
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Canton, Michigan, Forente stater, 48188
        • Rekruttering
        • Trinity Health Medical Center - Canton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Forente stater, 48118
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Forente stater, 48118
      • Dearborn, Michigan, Forente stater, 48124
        • Rekruttering
        • Corewell Health Dearborn Hospital
        • Hovedetterforsker:
          • Dana Zakalik
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Escanaba, Michigan, Forente stater, 49829
        • Rekruttering
        • OSF Saint Francis Hospital and Medical Group
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Farmington Hills, Michigan, Forente stater, 48336
        • Suspendert
        • Corewell Health Farmington Hills Hospital
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Genesys Hurley Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Hurley Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Flint, Michigan, Forente stater, 48503
        • Suspendert
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Cancer Hematology Centers - Flint
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Grand Rapids, Michigan, Forente stater, 49503
        • Rekruttering
        • Trinity Health Grand Rapids Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Grand Rapids, Michigan, Forente stater, 49503
        • Rekruttering
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49007
        • Rekruttering
        • Bronson Methodist Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49007
        • Rekruttering
        • West Michigan Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49009
        • Rekruttering
        • Beacon Kalamazoo Cancer Center
        • Hovedetterforsker:
          • Kathleen Y. Butler
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Kalamazoo, Michigan, Forente stater, 49048
        • Rekruttering
        • Beacon Kalamazoo
        • Hovedetterforsker:
          • Kathleen Y. Butler
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Lansing, Michigan, Forente stater, 48912
        • Rekruttering
        • University of Michigan Health - Sparrow Lansing
        • Hovedetterforsker:
          • Tareq Al baghdadi
        • Ta kontakt med:
      • Livonia, Michigan, Forente stater, 48154
        • Rekruttering
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Macomb, Michigan, Forente stater, 48044
        • Rekruttering
        • Henry Ford Saint John Hospital - Macomb Medical
        • Hovedetterforsker:
          • Tareq Al baghdadi
        • Ta kontakt med:
      • Manistique, Michigan, Forente stater, 49854
        • Rekruttering
        • Schoolcraft Memorial Hospital
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Muskegon, Michigan, Forente stater, 49444
        • Rekruttering
        • Trinity Health Muskegon Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Niles, Michigan, Forente stater, 49120
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Niles Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 616-391-1230
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Norton Shores, Michigan, Forente stater, 49444
        • Rekruttering
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Pontiac, Michigan, Forente stater, 48341
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Pontiac, Michigan, Forente stater, 48341
        • Rekruttering
        • Michigan Healthcare Professionals Pontiac
        • Hovedetterforsker:
          • Tareq Al baghdadi
        • Ta kontakt med:
      • Reed City, Michigan, Forente stater, 49677
        • Rekruttering
        • Corewell Health Reed City Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Royal Oak, Michigan, Forente stater, 48073
        • Rekruttering
        • Corewell Health William Beaumont University Hospital
        • Hovedetterforsker:
          • Dana Zakalik
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Royal Oak, Michigan, Forente stater, 48073
        • Rekruttering
        • Corewell Health Children's
        • Hovedetterforsker:
          • Dana Zakalik
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Saginaw, Michigan, Forente stater, 48604
        • Suspendert
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Forente stater, 48601
        • Rekruttering
        • MyMichigan Medical Center Saginaw
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Saint Joseph, Michigan, Forente stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forente stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Tawas City, Michigan, Forente stater, 48764
        • Rekruttering
        • MyMichigan Medical Center Tawas
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Traverse City, Michigan, Forente stater, 49684
        • Rekruttering
        • Munson Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Troy, Michigan, Forente stater, 48085
        • Rekruttering
        • Corewell Health Beaumont Troy Hospital
        • Hovedetterforsker:
          • Dana Zakalik
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • West Branch, Michigan, Forente stater, 48661
        • Suspendert
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, Forente stater, 49519
        • Rekruttering
        • University of Michigan Health - West
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Ypsilanti, Michigan, Forente stater, 48106
      • Ypsilanti, Michigan, Forente stater, 48197
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
    • Minnesota
      • Bemidji, Minnesota, Forente stater, 56601
      • Coon Rapids, Minnesota, Forente stater, 55433
        • Rekruttering
        • Mercy Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Deer River, Minnesota, Forente stater, 56636
        • Rekruttering
        • Essentia Health - Deer River Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Duluth, Minnesota, Forente stater, 55805
        • Rekruttering
        • Essentia Health Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Edina, Minnesota, Forente stater, 55435
        • Rekruttering
        • Fairview Southdale Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Edina, Minnesota, Forente stater, 55435
        • Rekruttering
        • Minnesota Oncology - Edina
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Hibbing, Minnesota, Forente stater, 55746
        • Rekruttering
        • Essentia Health Hibbing Clinic
        • Hovedetterforsker:
          • Bret E. Friday
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 218-786-3308
      • Maple Grove, Minnesota, Forente stater, 55369
        • Rekruttering
        • Fairview Clinics and Surgery Center Maple Grove
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Maplewood, Minnesota, Forente stater, 55109
        • Rekruttering
        • Saint John's Hospital - Healtheast
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Minneapolis, Minnesota, Forente stater, 55407
        • Rekruttering
        • Abbott-Northwestern Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Rochester, Minnesota, Forente stater, 55905
        • Rekruttering
        • Mayo Clinic in Rochester
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 855-776-0015
        • Hovedetterforsker:
          • Aaron S. Mansfield
      • Saint Louis Park, Minnesota, Forente stater, 55416
        • Rekruttering
        • Park Nicollet Clinic - Saint Louis Park
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Saint Paul, Minnesota, Forente stater, 55101
        • Rekruttering
        • Regions Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Saint Paul, Minnesota, Forente stater, 55102
        • Rekruttering
        • United Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Sandstone, Minnesota, Forente stater, 55072
        • Rekruttering
        • Essentia Health Sandstone
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Virginia, Minnesota, Forente stater, 55792
        • Rekruttering
        • Essentia Health Virginia Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
    • Mississippi
      • Columbus, Mississippi, Forente stater, 39705
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Golden Triangle
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Grenada, Mississippi, Forente stater, 38901
        • Rekruttering
        • Baptist Cancer Center-Grenada
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Gulfport, Mississippi, Forente stater, 39502
        • Aktiv, ikke rekrutterende
        • Gulfport Memorial Hospital
      • New Albany, Mississippi, Forente stater, 38652
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Union County
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Oxford, Mississippi, Forente stater, 38655
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Oxford
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Southhaven, Mississippi, Forente stater, 38671
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Desoto
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
    • Missouri
      • Cape Girardeau, Missouri, Forente stater, 63703
        • Rekruttering
        • Saint Francis Medical Center
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 573-334-2230
          • E-post: sfmc@sfmc.net
      • Chesterfield, Missouri, Forente stater, 63017
        • Rekruttering
        • Saint Luke's Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-205-6936
        • Hovedetterforsker:
          • Meera Rana
      • City of Saint Peters, Missouri, Forente stater, 63376
        • Rekruttering
        • Siteman Cancer Center at Saint Peters Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • Creve Coeur, Missouri, Forente stater, 63141
        • Rekruttering
        • Siteman Cancer Center at West County Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • Farmington, Missouri, Forente stater, 63640
        • Rekruttering
        • Parkland Health Center - Farmington
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Rolla, Missouri, Forente stater, 65401
        • Suspendert
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, Forente stater, 64506
        • Rekruttering
        • Heartland Regional Medical Center
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
      • Sainte Genevieve, Missouri, Forente stater, 63670
        • Rekruttering
        • Sainte Genevieve County Memorial Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Springfield, Missouri, Forente stater, 65804
        • Rekruttering
        • Mercy Hospital Springfield
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • Springfield, Missouri, Forente stater, 65807
        • Rekruttering
        • CoxHealth South Hospital
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • St Louis, Missouri, Forente stater, 63110
        • Rekruttering
        • Washington University School of Medicine
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forente stater, 63128
        • Rekruttering
        • Mercy Hospital South
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
      • St Louis, Missouri, Forente stater, 63141
        • Rekruttering
        • Mercy Hospital Saint Louis
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-251-7066
      • St Louis, Missouri, Forente stater, 63129
        • Rekruttering
        • Siteman Cancer Center-South County
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forente stater, 63136
        • Rekruttering
        • Siteman Cancer Center at Christian Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forente stater, 63131
        • Rekruttering
        • Missouri Baptist Medical Center
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Sullivan, Missouri, Forente stater, 63080
        • Rekruttering
        • Missouri Baptist Sullivan Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
    • Montana
      • Anaconda, Montana, Forente stater, 59711
        • Rekruttering
        • Community Hospital of Anaconda
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Billings, Montana, Forente stater, 59101
        • Rekruttering
        • Billings Clinic Cancer Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Bozeman, Montana, Forente stater, 59715
        • Rekruttering
        • Bozeman Health Deaconess Hospital
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Great Falls, Montana, Forente stater, 59405
        • Rekruttering
        • Benefis Sletten Cancer Institute
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Kalispell, Montana, Forente stater, 59901
        • Rekruttering
        • Logan Health Medical Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Missoula, Montana, Forente stater, 59804
        • Rekruttering
        • Community Medical Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
    • Nebraska
      • Bellevue, Nebraska, Forente stater, 68123
        • Aktiv, ikke rekrutterende
        • Nebraska Medicine-Bellevue
      • Omaha, Nebraska, Forente stater, 68198
        • Aktiv, ikke rekrutterende
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Forente stater, 68118
        • Aktiv, ikke rekrutterende
        • Nebraska Medicine-Village Pointe
    • Nevada
      • Las Vegas, Nevada, Forente stater, 89102
        • Rekruttering
        • OptumCare Cancer Care at Charleston
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forente stater, 89135
        • Rekruttering
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forente stater, 89144
        • Rekruttering
        • Summerlin Hospital Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forente stater, 89183
        • Suspendert
        • OptumCare Cancer Care at Fort Apache
      • Reno, Nevada, Forente stater, 89502
        • Rekruttering
        • Renown Regional Medical Center
        • Hovedetterforsker:
          • Khawaja S. Jahangir
        • Ta kontakt med:
    • New Jersey
      • Flemington, New Jersey, Forente stater, 08822
        • Rekruttering
        • Hunterdon Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 908-237-2330
        • Hovedetterforsker:
          • Myron E. Bednar
      • Lakewood, New Jersey, Forente stater, 08701
        • Rekruttering
        • Monmouth Medical Center Southern Campus
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
      • Livingston, New Jersey, Forente stater, 07039
        • Rekruttering
        • Cooperman Barnabas Medical Center
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 973-322-5200
      • Long Branch, New Jersey, Forente stater, 07740
        • Rekruttering
        • Monmouth Medical Center
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
      • Middletown, New Jersey, Forente stater, 07748
        • Rekruttering
        • Memorial Sloan Kettering Monmouth
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Alison M. Schram
      • New Brunswick, New Jersey, Forente stater, 08903
        • Rekruttering
        • Rutgers Cancer Institute of New Jersey
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
      • Pennington, New Jersey, Forente stater, 08534
        • Suspendert
        • Capital Health Medical Center-Hopewell
      • Sewell, New Jersey, Forente stater, 08080
        • Rekruttering
        • Sidney Kimmel Cancer Center Washington Township
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M. Johnson
      • Somerville, New Jersey, Forente stater, 08876
        • Rekruttering
        • Robert Wood Johnson University Hospital Somerset
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
      • Toms River, New Jersey, Forente stater, 08755
        • Rekruttering
        • Community Medical Center
        • Hovedetterforsker:
          • Patrick M. Boland
        • Ta kontakt med:
    • New Mexico
      • Albuquerque, New Mexico, Forente stater, 87106
        • Rekruttering
        • University of New Mexico Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bernard Tawfik
    • New York
      • Buffalo, New York, Forente stater, 14263
        • Rekruttering
        • Roswell Park Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ellis G. Levine
      • Commack, New York, Forente stater, 11725
        • Rekruttering
        • Memorial Sloan Kettering Commack
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Alison M. Schram
      • Harrison, New York, Forente stater, 10604
        • Rekruttering
        • Memorial Sloan Kettering Westchester
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Alison M. Schram
      • Mineola, New York, Forente stater, 11501
        • Rekruttering
        • NYU Langone Hospital - Long Island
        • Hovedetterforsker:
          • Kristen R. Spencer
        • Ta kontakt med:
      • New York, New York, Forente stater, 10065
        • Rekruttering
        • Memorial Sloan Kettering Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Alison M. Schram
      • New York, New York, Forente stater, 10016
        • Rekruttering
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • Hovedetterforsker:
          • Kristen R. Spencer
        • Ta kontakt med:
      • New York, New York, Forente stater, 10029
        • Rekruttering
        • Mount Sinai Hospital
        • Hovedetterforsker:
          • Deborah B. Doroshow
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-post: CCTO@mssm.edu
      • Rochester, New York, Forente stater, 14623
        • Aktiv, ikke rekrutterende
        • Pluta Cancer Center
      • Syracuse, New York, Forente stater, 13210
        • Rekruttering
        • State University of New York Upstate Medical University
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 315-464-5476
        • Hovedetterforsker:
          • Mary J. Cunningham
      • The Bronx, New York, Forente stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Einstein Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Balazs Halmos
      • The Bronx, New York, Forente stater, 10467
        • Rekruttering
        • Montefiore Medical Center - Moses Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Balazs Halmos
      • The Bronx, New York, Forente stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Weiler Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Balazs Halmos
    • North Carolina
      • Asheboro, North Carolina, Forente stater, 27205
        • Rekruttering
        • Cone Health MedCenter Asheboro
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vinay K. Gudena
      • Burlington, North Carolina, Forente stater, 27215
        • Rekruttering
        • Cone Health Cancer Center at Alamance Regional
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vinay K. Gudena
      • Clinton, North Carolina, Forente stater, 28328
        • Rekruttering
        • Southeastern Medical Oncology Center-Clinton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Samer S. Kasbari
      • Durham, North Carolina, Forente stater, 27710
        • Rekruttering
        • Duke University Medical Center
        • Hovedetterforsker:
          • Angeles A. Secord
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 888-275-3853
      • Goldsboro, North Carolina, Forente stater, 27534
        • Rekruttering
        • Southeastern Medical Oncology Center-Goldsboro
        • Ta kontakt med:
        • Hovedetterforsker:
          • Samer S. Kasbari
      • Greensboro, North Carolina, Forente stater, 27403
        • Rekruttering
        • Cone Health Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vinay K. Gudena
      • Greensboro, North Carolina, Forente stater, 27410
        • Rekruttering
        • Cone Health Cancer Center at Drawbridge Parkway
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vinay K. Gudena
      • High Point, North Carolina, Forente stater, 27262
        • Rekruttering
        • Hayworth Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 336-802-2500
        • Hovedetterforsker:
          • Anna Kuan-Celarier
      • Jacksonville, North Carolina, Forente stater, 28546
        • Rekruttering
        • Southeastern Medical Oncology Center-Jacksonville
        • Hovedetterforsker:
          • Samer S. Kasbari
        • Ta kontakt med:
      • Raleigh, North Carolina, Forente stater, 27607
        • Rekruttering
        • Duke Women's Cancer Care Raleigh
        • Hovedetterforsker:
          • Angeles A. Secord
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 919-785-4878
      • Reidsville, North Carolina, Forente stater, 27320
        • Rekruttering
        • Annie Penn Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vinay K. Gudena
      • Winston-Salem, North Carolina, Forente stater, 27157
        • Rekruttering
        • Wake Forest University Health Sciences
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 336-713-6771
        • Hovedetterforsker:
          • Anna Kuan-Celarier
    • North Dakota
      • Bismarck, North Dakota, Forente stater, 58501
      • Fargo, North Dakota, Forente stater, 58122
      • Fargo, North Dakota, Forente stater, 58122
    • Ohio
      • Athens, Ohio, Forente stater, 45701
        • Rekruttering
        • OhioHealth O'Bleness Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Avon, Ohio, Forente stater, 44011
        • Rekruttering
        • UH Seidman Cancer Center at UH Avon Health Center
        • Hovedetterforsker:
          • Alberto J. Montero
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-641-2422
      • Beachwood, Ohio, Forente stater, 44122
        • Rekruttering
        • UHHS-Chagrin Highlands Medical Center
        • Hovedetterforsker:
          • Alberto J. Montero
        • Ta kontakt med:
      • Belpre, Ohio, Forente stater, 45714
        • Rekruttering
        • Strecker Cancer Center-Belpre
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Canton, Ohio, Forente stater, 44710
        • Rekruttering
        • Aultman Health Foundation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sunitha Vemulapalli
      • Centerville, Ohio, Forente stater, 45459
        • Rekruttering
        • Miami Valley Hospital South
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Chillicothe, Ohio, Forente stater, 45601
        • Rekruttering
        • Adena Regional Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Cincinnati, Ohio, Forente stater, 45220
      • Cincinnati, Ohio, Forente stater, 45229
        • Aktiv, ikke rekrutterende
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Forente stater, 44106
        • Rekruttering
        • Case Western Reserve University
        • Hovedetterforsker:
          • Alberto J. Montero
        • Ta kontakt med:
      • Cleveland, Ohio, Forente stater, 44195
        • Aktiv, ikke rekrutterende
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Forente stater, 44111
        • Aktiv, ikke rekrutterende
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Forente stater, 43213
        • Rekruttering
        • Mount Carmel East Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Columbus, Ohio, Forente stater, 43214
        • Rekruttering
        • Columbus Oncology and Hematology Associates Inc
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43214
        • Rekruttering
        • Riverside Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43215
        • Rekruttering
        • Grant Medical Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43219
        • Rekruttering
        • The Mark H Zangmeister Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Columbus, Ohio, Forente stater, 43228
        • Rekruttering
        • Doctors Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43210
        • Rekruttering
        • Ohio State University Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Floor Backes
      • Dayton, Ohio, Forente stater, 45409
        • Rekruttering
        • Miami Valley Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forente stater, 45415
        • Rekruttering
        • Miami Valley Hospital North
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forente stater, 45409
        • Rekruttering
        • Premier Blood and Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 937-276-8320
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forente stater, 45415
        • Suspendert
        • Dayton Physician LLC - Englewood
      • Delaware, Ohio, Forente stater, 43015
        • Rekruttering
        • Delaware Health Center-Grady Cancer Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Delaware, Ohio, Forente stater, 43015
        • Rekruttering
        • Grady Memorial Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Dublin, Ohio, Forente stater, 43016
        • Rekruttering
        • Columbus Oncology and Hematology Associates
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Dublin, Ohio, Forente stater, 43016
        • Rekruttering
        • Dublin Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Findlay, Ohio, Forente stater, 45840
        • Suspendert
        • Armes Family Cancer Center
      • Franklin, Ohio, Forente stater, 45005-1066
        • Rekruttering
        • Atrium Medical Center-Middletown Regional Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Franklin, Ohio, Forente stater, 45005
        • Suspendert
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, Forente stater, 45331
        • Rekruttering
        • Miami Valley Cancer Care and Infusion
        • Hovedetterforsker:
          • Tarek M. Sabagh
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 937-569-7515
      • Grove City, Ohio, Forente stater, 43123
        • Rekruttering
        • Zangmeister Center Grove City
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Kettering, Ohio, Forente stater, 45429
        • Rekruttering
        • Kettering Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Howard M. Gross
      • Kettering, Ohio, Forente stater, 45409
        • Suspendert
        • Greater Dayton Cancer Center
      • Lancaster, Ohio, Forente stater, 43130
        • Rekruttering
        • Fairfield Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Mansfield, Ohio, Forente stater, 44903
        • Rekruttering
        • OhioHealth Mansfield Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Marion, Ohio, Forente stater, 43302
        • Rekruttering
        • OhioHealth Marion General Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Marysville, Ohio, Forente stater, 43040
        • Rekruttering
        • Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Mayfield Heights, Ohio, Forente stater, 44124
        • Aktiv, ikke rekrutterende
        • Hillcrest Hospital Cancer Center
      • Mentor, Ohio, Forente stater, 44060
        • Rekruttering
        • UH Seidman Cancer Center at Lake Health Mentor Campus
        • Hovedetterforsker:
          • Alberto J. Montero
        • Ta kontakt med:
      • Middleburg Heights, Ohio, Forente stater, 44130
        • Aktiv, ikke rekrutterende
        • UH Seidman Cancer Center at Southwest General Hospital
      • Mount Vernon, Ohio, Forente stater, 43050
        • Rekruttering
        • Knox Community Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Newark, Ohio, Forente stater, 43055
        • Rekruttering
        • Licking Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Perrysburg, Ohio, Forente stater, 43551
        • Rekruttering
        • Mercy Health - Perrysburg Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Pickerington, Ohio, Forente stater, 43147
        • Rekruttering
        • OhioHealth Pickerington Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Portsmouth, Ohio, Forente stater, 45662
        • Rekruttering
        • Southern Ohio Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Springfield, Ohio, Forente stater, 45504
        • Rekruttering
        • Springfield Regional Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Springfield, Ohio, Forente stater, 45504
        • Rekruttering
        • Springfield Regional Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Toledo, Ohio, Forente stater, 43623
        • Rekruttering
        • Mercy Health - Saint Anne Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Toledo, Ohio, Forente stater, 43623
        • Suspendert
        • Toledo Clinic Cancer Centers-Toledo
      • Troy, Ohio, Forente stater, 45373
        • Rekruttering
        • Upper Valley Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tarek M. Sabagh
      • Westerville, Ohio, Forente stater, 43081
        • Rekruttering
        • Saint Ann's Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
      • Westerville, Ohio, Forente stater, 43082
        • Rekruttering
        • OhioHealth Westerville Medical Campus/Westerville Cancer Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Youngstown, Ohio, Forente stater, 44501
        • Suspendert
        • Saint Elizabeth Youngstown Hospital
      • Zanesville, Ohio, Forente stater, 43701
        • Rekruttering
        • Genesis Healthcare System Cancer Care Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Aruna C. Gowda
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73104
        • Rekruttering
        • University of Oklahoma Health Sciences Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lauren E. Dockery
    • Oregon
      • Newberg, Oregon, Forente stater, 97132
        • Rekruttering
        • Providence Newberg Medical Center
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Ontario, Oregon, Forente stater, 97914
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Ontario
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Oregon City, Oregon, Forente stater, 97045
        • Rekruttering
        • Providence Willamette Falls Medical Center
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Portland, Oregon, Forente stater, 97239
        • Rekruttering
        • Oregon Health and Science University
        • Ta kontakt med:
        • Hovedetterforsker:
          • Christopher W. Ryan
      • Portland, Oregon, Forente stater, 97213
        • Rekruttering
        • Providence Portland Medical Center
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Portland, Oregon, Forente stater, 97225
        • Rekruttering
        • Providence Saint Vincent Medical Center
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
    • Pennsylvania
      • Allentown, Pennsylvania, Forente stater, 18103
        • Rekruttering
        • Lehigh Valley Hospital-Cedar Crest
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Altoona, Pennsylvania, Forente stater, 16601
        • Rekruttering
        • UPMC Altoona
        • Ta kontakt med:
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Bethlehem, Pennsylvania, Forente stater, 18017
        • Rekruttering
        • Lehigh Valley Hospital - Muhlenberg
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Bryn Mawr, Pennsylvania, Forente stater, 19010
        • Rekruttering
        • Bryn Mawr Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paul B. Gilman
      • East Stroudsburg, Pennsylvania, Forente stater, 18301
        • Rekruttering
        • Pocono Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Erie, Pennsylvania, Forente stater, 16505
        • Rekruttering
        • UPMC Hillman Cancer Center Erie
        • Hovedetterforsker:
          • Adam M. Brufsky
        • Ta kontakt med:
      • Greensburg, Pennsylvania, Forente stater, 15601
        • Rekruttering
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 724-838-1900
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Hazleton, Pennsylvania, Forente stater, 18201
        • Rekruttering
        • Lehigh Valley Hospital-Hazleton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tareq Al baghdadi
      • Mechanicsburg, Pennsylvania, Forente stater, 17050
        • Rekruttering
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Ta kontakt med:
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Media, Pennsylvania, Forente stater, 19063
        • Rekruttering
        • Riddle Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paul B. Gilman
      • Monroeville, Pennsylvania, Forente stater, 15146
        • Rekruttering
        • UPMC Hillman Cancer Center - Monroeville
        • Hovedetterforsker:
          • Adam M. Brufsky
        • Ta kontakt med:
      • Paoli, Pennsylvania, Forente stater, 19301
        • Rekruttering
        • Paoli Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paul B. Gilman
      • Philadelphia, Pennsylvania, Forente stater, 19107
        • Rekruttering
        • Thomas Jefferson University Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M. Johnson
      • Philadelphia, Pennsylvania, Forente stater, 19107
      • Philadelphia, Pennsylvania, Forente stater, 19111
        • Rekruttering
        • Fox Chase Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 215-728-4790
        • Hovedetterforsker:
          • Angela Jain
      • Pittsburgh, Pennsylvania, Forente stater, 15213
        • Rekruttering
        • UPMC-Magee Womens Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 412-647-2811
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Pittsburgh, Pennsylvania, Forente stater, 15237
        • Rekruttering
        • UPMC-Passavant Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 412-367-6454
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Pittsburgh, Pennsylvania, Forente stater, 15232
        • Rekruttering
        • UPMC Hillman Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 412-647-8073
        • Hovedetterforsker:
          • Adam M. Brufsky
      • Sayre, Pennsylvania, Forente stater, 18840
        • Rekruttering
        • Guthrie Medical Group PC-Robert Packer Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-836-0388
        • Hovedetterforsker:
          • Joyson Poulose
      • Willow Grove, Pennsylvania, Forente stater, 19090
        • Rekruttering
        • Asplundh Cancer Pavilion
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jennifer M. Johnson
      • Wynnewood, Pennsylvania, Forente stater, 19096
        • Rekruttering
        • Lankenau Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Paul B. Gilman
    • Rhode Island
      • Providence, Rhode Island, Forente stater, 02905
        • Rekruttering
        • Women and Infants Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 401-274-1122
        • Hovedetterforsker:
          • Paul A. DiSilvestro
      • Providence, Rhode Island, Forente stater, 02908
        • Rekruttering
        • Roger Williams Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ritesh Rathore
    • South Carolina
      • Boiling Springs, South Carolina, Forente stater, 29316
        • Rekruttering
        • Prisma Health Cancer Institute - Spartanburg
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Columbia, South Carolina, Forente stater, 29203
        • Rekruttering
        • Prisma Health Richland Hospital
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Easley, South Carolina, Forente stater, 29640
        • Rekruttering
        • Prisma Health Cancer Institute - Easley
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29605
        • Rekruttering
        • BI-LO Charities Children's Cancer Center
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29601
        • Rekruttering
        • Saint Francis Hospital
        • Hovedetterforsker:
          • Stephen H. Dyar
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29605
        • Rekruttering
        • Prisma Health Cancer Institute - Faris
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29607
        • Rekruttering
        • Saint Francis Cancer Center
        • Hovedetterforsker:
          • Stephen H. Dyar
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29605
        • Rekruttering
        • Prisma Health Cancer Institute - Butternut
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Greenville, South Carolina, Forente stater, 29615
        • Rekruttering
        • Prisma Health Cancer Institute - Eastside
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Greer, South Carolina, Forente stater, 29650
        • Rekruttering
        • Prisma Health Cancer Institute - Greer
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
      • Seneca, South Carolina, Forente stater, 29672
        • Rekruttering
        • Prisma Health Cancer Institute - Seneca
        • Hovedetterforsker:
          • Ki Y. Chung
        • Ta kontakt med:
    • South Dakota
      • Rapid City, South Dakota, Forente stater, 57701
        • Aktiv, ikke rekrutterende
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Forente stater, 57104
        • Rekruttering
        • Sanford Cancer Center Oncology Clinic
        • Hovedetterforsker:
          • Daniel Almquist
        • Ta kontakt med:
      • Sioux Falls, South Dakota, Forente stater, 57117-5134
    • Tennessee
      • Collierville, Tennessee, Forente stater, 38017
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Collierville
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Johnson City, Tennessee, Forente stater, 37604
        • Rekruttering
        • Regional Cancer Center at Johnson City Medical Center
        • Hovedetterforsker:
          • Asheesh Shipstone
        • Ta kontakt med:
      • Kingsport, Tennessee, Forente stater, 37660
        • Rekruttering
        • Ballad Health Cancer Care - Kingsport
        • Hovedetterforsker:
          • Asheesh Shipstone
        • Ta kontakt med:
      • Memphis, Tennessee, Forente stater, 38120
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Memphis
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew J. Benefield
      • Nashville, Tennessee, Forente stater, 37232
        • Rekruttering
        • Vanderbilt University/Ingram Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Hovedetterforsker:
          • Jennifer H. Choe
      • Nashville, Tennessee, Forente stater, 37204
        • Rekruttering
        • Vanderbilt Breast Center at One Hundred Oaks
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Hovedetterforsker:
          • Jennifer H. Choe
    • Texas
      • Abilene, Texas, Forente stater, 79601
        • Rekruttering
        • Hendrick Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 325-670-6340
        • Hovedetterforsker:
          • Jose C. Velasco Di Domenico
      • Dallas, Texas, Forente stater, 75390
        • Rekruttering
        • UT Southwestern/Simmons Cancer Center-Dallas
        • Ta kontakt med:
        • Hovedetterforsker:
          • Devin E. Jones
      • Houston, Texas, Forente stater, 77030
        • Aktiv, ikke rekrutterende
        • Houston Methodist Hospital
      • Houston, Texas, Forente stater, 77026-1967
        • Rekruttering
        • Lyndon Baines Johnson General Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 713-566-5000
        • Hovedetterforsker:
          • Funda Meric-Bernstam
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • UT MD Anderson Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Funda Meric-Bernstam
      • Houston, Texas, Forente stater, 77070
        • Aktiv, ikke rekrutterende
        • Methodist Willowbrook Hospital
      • Houston, Texas, Forente stater, 77094
        • Aktiv, ikke rekrutterende
        • Houston Methodist West Hospital
      • Lubbock, Texas, Forente stater, 79410
        • Aktiv, ikke rekrutterende
        • Covenant Medical Center-Lakeside
      • Nassau Bay, Texas, Forente stater, 77058
        • Aktiv, ikke rekrutterende
        • Houston Methodist Saint John Hospital
      • Sugar Land, Texas, Forente stater, 77479
        • Aktiv, ikke rekrutterende
        • Houston Methodist Sugar Land Hospital
      • Temple, Texas, Forente stater, 76508
        • Rekruttering
        • Scott and White Memorial Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 254-724-5407
        • Hovedetterforsker:
          • Lucas Wong
      • The Woodlands, Texas, Forente stater, 77385
        • Aktiv, ikke rekrutterende
        • Houston Methodist The Woodlands Hospital
    • Virginia
      • Bristol, Virginia, Forente stater, 24201
        • Rekruttering
        • Ballad Health Cancer Care - Bristol
        • Hovedetterforsker:
          • Asheesh Shipstone
        • Ta kontakt med:
      • Charlottesville, Virginia, Forente stater, 22908
        • Rekruttering
        • University of Virginia Cancer Center
        • Hovedetterforsker:
          • Matthew J. Reilley
        • Ta kontakt med:
      • Fairfax, Virginia, Forente stater, 22031
        • Rekruttering
        • Inova Schar Cancer Institute
        • Hovedetterforsker:
          • Timothy L. Cannon
        • Ta kontakt med:
      • Falls Church, Virginia, Forente stater, 22042
        • Rekruttering
        • Inova Fairfax Hospital
        • Hovedetterforsker:
          • Timothy L. Cannon
        • Ta kontakt med:
      • Richmond, Virginia, Forente stater, 23235
        • Rekruttering
        • VCU Massey Cancer Center at Stony Point
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew Poklepovic
      • Richmond, Virginia, Forente stater, 23229
        • Aktiv, ikke rekrutterende
        • Virginia Cancer Institute
      • Richmond, Virginia, Forente stater, 23229
        • Rekruttering
        • Henrico Doctor's Hospital
        • Hovedetterforsker:
          • Andrew S. Kennedy
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 804-591-4152
      • Richmond, Virginia, Forente stater, 23298
        • Rekruttering
        • VCU Massey Comprehensive Cancer Center
        • Hovedetterforsker:
          • Andrew Poklepovic
        • Ta kontakt med:
      • Roanoke, Virginia, Forente stater, 24033
        • Rekruttering
        • Carilion Roanoke Memorial Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 540-985-8510
        • Hovedetterforsker:
          • Andrew Poklepovic
      • South Hill, Virginia, Forente stater, 23970
        • Rekruttering
        • VCU Community Memorial Health Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew Poklepovic
    • Washington
      • Edmonds, Washington, Forente stater, 98026
        • Rekruttering
        • Swedish Cancer Institute-Edmonds
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Issaquah, Washington, Forente stater, 98029
        • Rekruttering
        • Swedish Cancer Institute-Issaquah
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Lacey, Washington, Forente stater, 98503
        • Rekruttering
        • Providence Regional Cancer System-Lacey
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Renton, Washington, Forente stater, 98055
        • Rekruttering
        • Valley Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
      • Seattle, Washington, Forente stater, 98122
        • Rekruttering
        • Swedish Medical Center-First Hill
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Walla Walla, Washington, Forente stater, 99362
        • Rekruttering
        • Providence Saint Mary Regional Cancer Center
        • Hovedetterforsker:
          • Alison K. Conlin
        • Ta kontakt med:
      • Yakima, Washington, Forente stater, 98902
        • Rekruttering
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Khawaja S. Jahangir
    • West Virginia
      • Charleston, West Virginia, Forente stater, 25304
        • Rekruttering
        • Vandalia Health/CAMC Institute for Academic Medicine
        • Hovedetterforsker:
          • Ahmed A. Khalid
        • Ta kontakt med:
      • Huntington, West Virginia, Forente stater, 25701
        • Rekruttering
        • Edwards Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toni O. Pacioles
      • Morgantown, West Virginia, Forente stater, 26506
        • Rekruttering
        • West Virginia University Healthcare
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mohammed Almubarak
    • Wisconsin
      • Appleton, Wisconsin, Forente stater, 54911
        • Rekruttering
        • ThedaCare Regional Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Appleton, Wisconsin, Forente stater, 54911
        • Rekruttering
        • ThedaCare Regional Medical Center - Appleton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Ashland, Wisconsin, Forente stater, 54806
        • Rekruttering
        • Duluth Clinic Ashland
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Berlin, Wisconsin, Forente stater, 54923
        • Rekruttering
        • ThedaCare Cancer Care - Berlin
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Burlington, Wisconsin, Forente stater, 53105
        • Rekruttering
        • Aurora Cancer Care-Southern Lakes VLCC
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Eau Claire, Wisconsin, Forente stater, 54701
      • Germantown, Wisconsin, Forente stater, 53022
        • Rekruttering
        • Aurora Health Care Germantown Health Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Grafton, Wisconsin, Forente stater, 53024
        • Rekruttering
        • Aurora Cancer Care-Grafton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Green Bay, Wisconsin, Forente stater, 54311
        • Rekruttering
        • Aurora BayCare Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Green Bay, Wisconsin, Forente stater, 54301
        • Rekruttering
        • Saint Vincent Hospital Cancer Center Green Bay
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Green Bay, Wisconsin, Forente stater, 54303
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Janesville, Wisconsin, Forente stater, 53548
        • Rekruttering
        • Mercyhealth Hospital and Cancer Center - Janesville
        • Ta kontakt med:
        • Hovedetterforsker:
          • Emily G. Robinson
      • Kenosha, Wisconsin, Forente stater, 53142
        • Rekruttering
        • Aurora Cancer Care-Kenosha South
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • La Crosse, Wisconsin, Forente stater, 54601
        • Rekruttering
        • Gundersen Lutheran Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kurt Oettel
      • Madison, Wisconsin, Forente stater, 53792
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Hovedetterforsker:
          • Nataliya V. Uboha
        • Ta kontakt med:
      • Madison, Wisconsin, Forente stater, 53718
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • Hovedetterforsker:
          • Nataliya V. Uboha
        • Ta kontakt med:
      • Marinette, Wisconsin, Forente stater, 54143
        • Rekruttering
        • Aurora Bay Area Medical Group-Marinette
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Marshfield, Wisconsin, Forente stater, 54449
      • Milwaukee, Wisconsin, Forente stater, 53209
        • Rekruttering
        • Aurora Cancer Care-Milwaukee
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Milwaukee, Wisconsin, Forente stater, 53215
        • Rekruttering
        • Aurora Saint Luke's Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Milwaukee, Wisconsin, Forente stater, 53233
        • Rekruttering
        • Aurora Sinai Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Minocqua, Wisconsin, Forente stater, 54548
      • Mukwonago, Wisconsin, Forente stater, 53149
        • Rekruttering
        • ProHealth D N Greenwald Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Timothy R. Wassenaar
      • Neenah, Wisconsin, Forente stater, 54956
        • Rekruttering
        • ThedaCare Regional Medical Center - Neenah
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • New London, Wisconsin, Forente stater, 54961
        • Rekruttering
        • ThedaCare Cancer Care - New London
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • New Richmond, Wisconsin, Forente stater, 54017
        • Rekruttering
        • Cancer Center of Western Wisconsin
        • Ta kontakt med:
        • Hovedetterforsker:
          • David M. King
      • Oconomowoc, Wisconsin, Forente stater, 53066
        • Rekruttering
        • ProHealth Oconomowoc Memorial Hospital
        • Hovedetterforsker:
          • Timothy R. Wassenaar
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 262-928-7878
      • Oconto Falls, Wisconsin, Forente stater, 54154
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Oshkosh, Wisconsin, Forente stater, 54904
        • Rekruttering
        • Vince Lombardi Cancer Clinic - Oshkosh
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Oshkosh, Wisconsin, Forente stater, 54904
        • Rekruttering
        • ThedaCare Cancer Care - Oshkosh
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Racine, Wisconsin, Forente stater, 53406
        • Rekruttering
        • Aurora Cancer Care-Racine
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Rice Lake, Wisconsin, Forente stater, 54868
      • Shawano, Wisconsin, Forente stater, 54166
        • Rekruttering
        • ThedaCare Cancer Care - Shawano
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Vince Lombardi Cancer Clinic-Sheboygan
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Sheboygan Physicians Group
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Stevens Point, Wisconsin, Forente stater, 54482
      • Sturgeon Bay, Wisconsin, Forente stater, 54235-1495
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Hovedetterforsker:
          • Brian L. Burnette
        • Ta kontakt med:
      • Summit, Wisconsin, Forente stater, 53066
        • Rekruttering
        • Aurora Medical Center in Summit
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Two Rivers, Wisconsin, Forente stater, 54241
        • Rekruttering
        • Vince Lombardi Cancer Clinic-Two Rivers
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Waukesha, Wisconsin, Forente stater, 53188
        • Rekruttering
        • UW Cancer Center at ProHealth Care
        • Hovedetterforsker:
          • Timothy R. Wassenaar
        • Ta kontakt med:
      • Waupaca, Wisconsin, Forente stater, 54981
        • Rekruttering
        • ThedaCare Cancer Care - Waupaca
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthias Weiss
      • Wauwatosa, Wisconsin, Forente stater, 53226
        • Rekruttering
        • Aurora Cancer Care-Milwaukee West
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • West Allis, Wisconsin, Forente stater, 53227
        • Rekruttering
        • Aurora West Allis Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Antony Ruggeri
      • Weston, Wisconsin, Forente stater, 54476
      • Bayamón, Puerto Rico, 00961
        • Rekruttering
        • Puerto Rico Hematology Oncology Group
        • Hovedetterforsker:
          • Luis J. Santos Reyes
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 787-780-2865
      • Manati, Puerto Rico, 00674
        • Rekruttering
        • Doctors Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 787-621-4397
        • Hovedetterforsker:
          • Luis J. Santos Reyes
      • San Juan, Puerto Rico, 00927
        • Rekruttering
        • Centro Comprensivo de Cancer de UPR
        • Hovedetterforsker:
          • Luis J. Santos Reyes
        • Ta kontakt med:
      • San Juan, Puerto Rico, 00927
        • Rekruttering
        • PROncology
        • Hovedetterforsker:
          • Luis J. Santos Reyes
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patient must have measurable disease

  • Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status between 0-2 OR patient must have Lansky performance status of >= 50% or Karnofsky performance status of >= 50%

  • Patient must be deemed potentially eligible for a ComboMATCH Treatment Trial as assessed by the enrolling provider

  • All patients must have sequencing results available from a National Cancer Institute (NCI) credentialed Designated Laboratory (DL)

  • Patients must have locally advanced or advanced histologically documented solid tumors requiring therapy and meet one of the following criteria:

    • Patients must have progressed on at least one line of standard systemic therapy OR
    • Patients whose disease has no standard treatment that has been shown to prolong overall survival
  • Patient must meet one of the following requirements:

    • Patients 18 years and older who have tumor amenable to minimal risk image-guided or direct vision biopsy and must be willing and able to undergo a tumor biopsy to obtain samples for research if the patient is to enroll in a ComboMATCH treatment trial OR

    • Patients 18 years and older who do not have disease that is biopsiable at minimal risk to the patient must confirm availability of an archival tumor tissue specimen for submission for research if the patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria:

      • Tissue must have been collected within 12 months prior to registration to the EAY191 Registration Trial
      • Patient must not have had a Response Evaluation Criteria in Solid Tumors (RECIST) response (complete response [CR] or partial response [PR]) to any intervening therapy after collection of the tissue
      • Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available OR
    • Patients under 18 years old must confirm availability of an archival tumor tissue specimen for submission for research if patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria:

      • Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available
    • NOTE: See specific ComboMATCH Treatment Trial protocol for tissue collection and management instructions. Performance of the mandatory research biopsy or submission of pre-trial formalin-fixed paraffin-embedded (FFPE) and collection and submission of the blood specimens for the integrated studies will be performed under the consent authority of the specific treatment trial protocol to which the patient is registered. No procedures to collect specimens for research only are to be performed for patients registered to the EAY191 Registration Trial only

  • NOTE: Each ComboMATCH Treatment Trial contains specific eligibility criteria. If patient is found to not be eligible for the assigned ComboMATCH Treatment Trial, indication of ineligibility will trigger re-evaluation and potential assignment to another Treatment Trial

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Screening
  • Tildeling: Randomisert
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: EAY191-A2 (Cohort 1, Arm A)

Cohort 1, Arm A: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given PO

Andre navn:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hemmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • Piqray
  • BYL719
  • Fosfoinositid 3-kinasehemmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentell: EAY191-A2 (Cohort 2, Arm B)

Cohort 2, Arm B: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given PO

Andre navn:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hemmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • Piqray
  • BYL719
  • Fosfoinositid 3-kinasehemmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentell: EAY191-A2 (Cohort 2, Arm C)

Cohort 2, Arm C: Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients experiencing disease progression have the option to migrate to Cohort 3, Arm D. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given PO

Andre navn:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hemmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-A2 (Cohort 3, Arm D)

Cohort 3, Arm D: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given PO

Andre navn:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hemmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • Piqray
  • BYL719
  • Fosfoinositid 3-kinasehemmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentell: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)

Patients receive palbociclib PO and binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • Ibrance
  • 6-acetyl-8-cyklopentyl-5-metyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-on
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991
  • PD0332991

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-A3 Monotherapy Cohort 1 (binimetinib)

Patients receive binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)

Patients receive leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or a FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

Given IV

Andre navn:
  • 5-Fluracil
  • Fluracil
  • 5 Fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-fluor-2,4(1H,3H)-pyrimidindion
  • 5-Fluorouracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluoro Uracil
  • Fluouracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given IV

Andre navn:
  • 1-OHP
  • Dakotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocykloheksan oksalatoplatina
  • JM-83
  • Oksalatoplatin
  • Oksalatoplatina
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Given IV

Andre navn:
  • Folinsyre

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Patients receive binimetinib PO, leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or an FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated

Given IV

Andre navn:
  • 5-Fluracil
  • Fluracil
  • 5 Fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-fluor-2,4(1H,3H)-pyrimidindion
  • 5-Fluorouracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluoro Uracil
  • Fluouracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo PET

Andre navn:
  • Medisinsk bildebehandling, positronemisjonstomografi
  • KJÆLEDYR
  • PET-skanning
  • Positron Emission Tomography Scan
  • Positron-utslippstomografi
  • PT
  • Positronemisjonstomografi (prosedyre)

Given PO

Andre navn:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IV

Andre navn:
  • 1-OHP
  • Dakotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocykloheksan oksalatoplatina
  • JM-83
  • Oksalatoplatin
  • Oksalatoplatina
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Given IV

Andre navn:
  • Folinsyre

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-E4 (taxane therapy)

Patients receive nilotinib hydrochloride monohydrate PO BID on days 1-28 and paclitaxel IV over 1 hour on days 1, 8, and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT or MRI during screening or cycle 1 day 1, every 2 cycles for 1 year, every 3 cycles for patients on study for more than 1 year, and every 4 cycles for patients on study for more than 3 years and may also undergo CT or MRI during follow-up every 3 months for 2 years and then every 6 months for 1 year if clinically indicated. Patients also undergo collection of blood samples at baseline, cycle 2 day 1, and optionally at progression as well as tumor biopsy at baseline and optionally at progression.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • AMN 107
  • Tasigna
  • AMN107
  • Nilotinib Monohydroklorid Monohydrat
  • AMN-107

Given PO or IV

Andre navn:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat
Eksperimentell: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)

Patients receive sotorasib PO QD on days 1-28 and panitumumab IV on days 1 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IV

Andre navn:
  • ABX-EGF
  • ABX-EGF monoklonalt antistoff
  • ABX-EGF, klon E7.6.3
  • MoAb ABX-EGF
  • Monoklonalt antistoff ABX-EGF
  • Vectibix
  • E7.6.3
  • Humant IgG2K monoklonalt antistoff
  • MoAb E7.6.3
  • Monoklonalt antistoff E7.6.3

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Aktiv komparator: EAY191-E5 Cohort I Arm B (sotorasib)

Patients receive sotorasib PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients with disease progression may cross-over to cohort II. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Eksperimentell: EAY191-E5 Cohort II (sotorasib)

Patients receive combination therapy as in EAY191-E5 Arm A.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IV

Andre navn:
  • ABX-EGF
  • ABX-EGF monoklonalt antistoff
  • ABX-EGF, klon E7.6.3
  • MoAb ABX-EGF
  • Monoklonalt antistoff ABX-EGF
  • Vectibix
  • E7.6.3
  • Humant IgG2K monoklonalt antistoff
  • MoAb E7.6.3
  • Monoklonalt antistoff E7.6.3

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Eksperimentell: EAY191-N2 Cohort I (Arm I) (NF1 mutations)

Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles and binimetinib PO BID on days 15 to 28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a CT, MRI, or bone scan, ECHO or MUGA, and tumor biopsy, as well as possible blood sample collection during screening and on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IM

Andre navn:
  • Faslodex
  • Faslodex (ICI 182 780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-N2 Cohort I (Arm II) (NF1 mutations)

Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who progress on fulvestrant alone may migrate to cohort II if they meet the migration eligibility criteria. Patients not willing to migrate to cohort II will have further therapy at the investigator's discretion. Patients undergo a CT, MRI, or bone scan and tumor biopsy, as well as ECHO or MUGA and possible blood sample collection during screening and on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IM

Andre navn:
  • Faslodex
  • Faslodex (ICI 182 780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-N2 Cohort II (NF1 mutations)

Patients receive fulvestrant IM on day 1 of each cycle and binimetinib PO BID on days 15-28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo a CT, MRI, or bone scan, ECHO or MUGA and tumor biopsy, as well as possible blood sample collection during screening and on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IM

Andre navn:
  • Faslodex
  • Faslodex (ICI 182 780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navn:
  • Benscintigrafi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: EAY191-N4 Arm I (RAS pathway mutations)

Patients receive selumetinib PO BID and olaparib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

Undergo bone marrow biopsy

Andre navn:
  • Biopsi av benmarg
  • Biopsi, benmarg

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo bone marrow aspiration

Given PO

Andre navn:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hemmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Undergo tumor mutational screening

Given PO

Andre navn:
  • AZD-6244 Hydrogensulfat
  • AZD6244 Hydrogensulfat
  • Koselugo
  • Selumetinibsulfat
Aktiv komparator: EAY191-N4 Arm II (RAS pathway mutations)

Patients receive selumetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

Undergo bone marrow biopsy

Andre navn:
  • Biopsi av benmarg
  • Biopsi, benmarg

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo bone marrow aspiration

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Undergo tumor mutational screening

Given PO

Andre navn:
  • AZD-6244 Hydrogensulfat
  • AZD6244 Hydrogensulfat
  • Koselugo
  • Selumetinibsulfat
Aktiv komparator: EAY191-N5 Arm I (neratinib maleate)

Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • Nerlynx
  • 2-butenamid, N-(4-((3-klor-4-(2-pyridinylmetoksy)fenyl)amino)-3-cyano-7-etoksy-6-kinolinyl)-4-(dimetylamino)-, (2E) -, (2Z)-2-butendioat (1:1)
  • HKI-272 maleat
  • VANNFRITT NERATINIB MALEAT
Eksperimentell: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo ECHO

Andre navn:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navn:
  • Skanning av blodbasseng
  • Likevektsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-skanning
  • Synchronized Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid ventrikulogramskanning
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • Ibrance
  • 6-acetyl-8-cyklopentyl-5-metyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-on
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991
  • PD0332991

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO

Andre navn:
  • Nerlynx
  • 2-butenamid, N-(4-((3-klor-4-(2-pyridinylmetoksy)fenyl)amino)-3-cyano-7-etoksy-6-kinolinyl)-4-(dimetylamino)-, (2E) -, (2Z)-2-butendioat (1:1)
  • HKI-272 maleat
  • VANNFRITT NERATINIB MALEAT
Eksperimentell: EAY191-S3 (activating AKT mutation)

Patients receive paclitaxel IV on days 1, 8, and 15 and ipatasertib PO on days 1-21 of each cycle. Treatment repeats every 28 days for up to 35 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo a CT or MRI and blood collection throughout the trial. Patients also undergo a tumor biopsy during screening and optionally during follow-up.

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo biopsy

Andre navn:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navn:
  • GDC-0068
  • RG7440
  • RG-7440
  • GDC 0068
  • GDC0068
  • RG 7440

Undergo blood collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Given PO or IV

Andre navn:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Accrual of patients to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years
Assignment of patients to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years
Enrollment rates to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Rate of positive outcomes within the treatment trial defined cohorts
Tidsramme: Up to 8 years

For each cohort in each treatment trial there is a defined primary efficacy endpoint (usually progression free survival [PFS] or overall response rate) and defined primary analysis for evaluating the primary endpoint. As cohorts are completed, whether they meet the criteria for a positive primary outcome will be determined. Positive treatment cohort outcome (on primary endpoint) will be analyzed as a binary random variable. The raw proportion of treatment cohorts with positive outcomes and an exact binomial confidence interval will be computed. If there are a sufficient number of treatment cohorts, logistic regression analysis will be performed examining the relationship of treatment cohort characteristics with successful outcomes. The goal is to achieve a rate of at least 30% with positive outcomes, both overall and in the subset of treatment trials based on in vivo models.

Up to 8 years

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Concordance between whole exome sequencing (WES) and results from the Designated Laboratory (DL)
Tidsramme: Up to 8 years

Whole exome and other sequencing will be performed on mandatory tissue biopsies or, if no biopsy tissue is available, on submitted formalin-fixed paraffin-embedded tissue. These assays will be done in a clinical laboratory (e.g., Clinical Laboratory Improvement Act-compliant); but results will not be returned to the clinical site. Results will be used to compare with the DL assay results. This comparison will be required to conduct an important secondary analysis of the primary endpoint in each cohort in each treatment trial, restricting to those cases that are concordant between WES and the result from the DL that was the basis for enrollment (integrated).

Up to 8 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: James M Ford, ECOG-ACRIN Cancer Research Group

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

7. april 2023

Primær fullføring (Antatt)

1. juli 2030

Studiet fullført (Antatt)

1. juli 2030

Datoer for studieregistrering

Først innsendt

27. september 2022

Først innsendt som oppfylte QC-kriteriene

29. september 2022

Først lagt ut (Faktiske)

3. oktober 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

11. november 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • NCI-2022-06842
  • U10CA180820 (U.S. NIH-stipend/kontrakt)
  • NCI-2022-06842 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
  • EAY191 (Annen identifikator: CTEP)
  • EAY191 (Annen identifikator: ECOG-ACRIN Cancer Research Group)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere